ArticleBlood cell therapy2025

PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation.

Ling Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.